Medtronic wins partial victory in off-label stents case
Medtronic wins partial victory in off-label stents case Mass Device
View ArticleStents lose their edge over surgical plaque removal after the first year,...
Stents lose their edge over surgical plaque removal after the first year, researchers say Mass Device
View ArticleStents: FDA approves TriVascular's Ovation stent graft system | Regulatory...
Stents: FDA approves TriVascular's Ovation stent graft system | Regulatory Roundup Mass Device
View ArticleOrbusNeich releases data on combo stent, Genous
OrbusNeich releases data on combo stent, Genous FierceMedicalDevice
View ArticleAbbott, BSX Face New Stent Rival Which Has attracted Ex-Celgene Chief, Some...
Abbott, BSX Face New Stent Rival Which Has attracted Ex-Celgene Chief, Some Investors Forbes
View ArticleFDA requires BSX to include stent "shrinkage" risk in Promus Element label
FDA requires BSX to include stent "shrinkage" risk in Promus Element label Mass Device
View ArticleStents: Drug-eluters beat bare metal for patients over 85
Stents: Drug-eluters beat bare metal for patients over 85 Mass Device
View ArticleAbbott Labs Wins Ruling Over J&J, Wyeth in Xience Stent Case on Patents
Abbott Labs Wins Ruling Over J&J, Wyeth in Xience Stent Case on Patents Bloomberg
View ArticlePublic Citizen Chides FDA for Failing to Recall Stryker Stent
Public Citizen Chides FDA for Failing to Recall Stryker Stent injuryboard
View ArticleDrug-eluting stent: Boston Scientific launches new Promus Element Plus in EU
Drug-eluting stent: Boston Scientific launches new Promus Element Plus in EU Mass Device
View ArticlePills as good as stents for stable heart patients-analysis
Pills as good as stents for stable heart patients-analysis Reuters
View ArticleUS FDA to decide next step for Stryker brain stent
US FDA to decide next step for Stryker brain stent Reuters
View ArticleJ&J seeks Xarelto approval to prevent stent clots
J&J seeks Xarelto approval to prevent stent clots Reuters
View ArticleStudy: Women fare worse with stents than men
Study: Women fare worse with stents than men FierceMedicalDevice
View ArticleJ&J Subsidiary Cordis Buys Flexible Stenting Solutions
J&J Subsidiary Cordis Buys Flexible Stenting Solutions Motley Fool
View ArticleJ&J Wins Reversal of $482 Million Patent Verdict Over Stents
J&J Wins Reversal of $482 Million Patent Verdict Over Stents Bloomberg
View ArticleBoston Scientific Entangled in Patent Issues
Boston Scientific Entangled in Patent Issues Yahoo/Zacks
View ArticleBayer says FDA requests more data on Xarelto for stent patients
Bayer says FDA requests more data on Xarelto for stent patients Reuters
View Article
